EP 1140084 A1 20011010 - NOVEL FORMULATION
Title (en)
NOVEL FORMULATION
Title (de)
NEUE FORMULIERUNG
Title (fr)
NOUVELLE FORMULATION
Publication
Application
Priority
- DK 9900699 W 19991214
- DK PA199801703 A 19981222
Abstract (en)
[origin: WO0037081A1] A modified release formulation contains (R)-1-(3-( 10,11- Dihydro- 5H-dibenzo [a,d]cyclo -hepten-5- ylidene) -1-propyl) -3-piperidinecarboxylic acid or pharmaceutically compound thereof.
IPC 1-7
IPC 8 full level
C07D 211/60 (2006.01); A61K 9/20 (2006.01); A61K 9/22 (2006.01); A61K 9/28 (2006.01); A61K 9/30 (2006.01); A61K 9/48 (2006.01); A61K 9/52 (2006.01); A61K 31/445 (2006.01); A61K 47/34 (2006.01); A61K 47/38 (2006.01); A61P 3/10 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP)
A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61P 3/10 (2017.12); A61P 29/00 (2017.12)
Citation (search report)
See references of WO 0037081A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0037081 A1 20000629; AU 1649700 A 20000712; EP 1140084 A1 20011010; JP 2002532551 A 20021002
DOCDB simple family (application)
DK 9900699 W 19991214; AU 1649700 A 19991214; EP 99959252 A 19991214; JP 2000589192 A 19991214